Kalvista Pharmaceuticals Inc (KALV)
SG&A Expenses
$198.25M
TTM · Period ending: · USD
KALV SG&A Expenses
Latest reported$198.25Mperiod ending
Latest reported$198.25Mperiod ending
KALV SG&A Expenses ($1.41M → $198.25M)
Annual SG&A Expenses
High-resolution chart · PNG
KALV sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 183,741,000 | |
| 116,286,000 | |
| 54,278,000 | |
| 30,595,000 | |
| 26,446,000 | |
| 16,637,000 | |
| 13,029,000 | |
| 10,926,000 | |
| 8,862,000 | |
| 11,177,000 | |
| 2,653,000 | |
| 1,608,000 | |
| 1,402,000 | |
| 1,412,000 |